JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $159 | -100.0% | 143,218 | -0.8% | 0.00% | 0.0% |
| Q3 2022 | $338,000 | -22.8% | 144,403 | -0.1% | 0.00% | -50.0% |
| Q2 2022 | $438,000 | -55.5% | 144,575 | -0.2% | 0.00% | -50.0% |
| Q1 2022 | $984,000 | -18.6% | 144,929 | +0.1% | 0.00% | -20.0% |
| Q4 2021 | $1,209,000 | +8.8% | 144,749 | -3.2% | 0.01% | -16.7% |
| Q3 2021 | $1,111,000 | +9.4% | 149,463 | +0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,016,000 | -33.8% | 149,455 | +0.0% | 0.01% | -45.5% |
| Q1 2021 | $1,534,000 | +46.7% | 149,397 | 0.0% | 0.01% | +37.5% |
| Q4 2020 | $1,046,000 | -14.2% | 149,397 | 0.0% | 0.01% | -27.3% |
| Q3 2020 | $1,219,000 | +18.2% | 149,397 | -0.0% | 0.01% | +10.0% |
| Q2 2020 | $1,031,000 | +45.2% | 149,428 | +0.0% | 0.01% | +11.1% |
| Q1 2020 | $710,000 | – | 149,397 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,087,961 | $2,012,728 | 1.74% |
| Opaleye Management Inc. | 2,880,000 | $5,328,000 | 1.60% |
| TANG CAPITAL MANAGEMENT LLC | 5,300,087 | $9,805,161 | 1.46% |
| Ardent Capital Management, Inc. | 923,463 | $1,708,407 | 1.23% |
| Beryl Capital Management LLC | 610,831 | $1,130,037 | 0.89% |
| Arena Investors LP | 610,639 | $1,129,682 | 0.88% |
| Omega Fund Management, LLC | 275,513 | $509,699 | 0.33% |
| Deep Track Capital, LP | 4,259,653 | $7,880,358 | 0.32% |
| PenderFund Capital Management Ltd. | 246,310 | $616 | 0.19% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 425,100 | $786,435 | 0.15% |